Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-15

Clinical Trial Update: rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency [Phase 2]

View source ↗

Summary

Phase 2 trial investigating rhGH and rhIGF-1 combination therapy for short stature associated with IGF-1 deficiency; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rhGH and rhIGF-1 combination therapy

Snippet

Sponsor: Ipsen | Conditions: Insulin-like Growth Factor-1 Deficiency | Phase 2 | Status: TERMINATED | Results posted: 2015-12-15